Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Giovanni Scambia, Sandro Pignata, Giulia Amadio, S. Lepori, A. M. Mosconi, Carmela Pisano, Roberto Sabbatini, G. Artioli, T. Gamucci, Marilena Di Napoli, Ettore Capoluongo, Vienna Ludovini, Gabriella Ferrandina

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences